A Phase 2 Study to Evaluate the Safety and Efficacy of YRA-1909 in Patients With Rheumatoid Arthritis
Status:
Completed
Trial end date:
2019-11-19
Target enrollment:
Participant gender:
Summary
This is a multicenter, randomized, double-blind phase2 study to evaluate the safety and
investigate the efficacy of YRA-1909 in Patients with Rheumatoid Arthritis who are on a
stable dose of Methotrexate(MTX) and who have an inadequate response to MTX(MTX-IR).